Literature DB >> 19825337

Dialysis dose and nutrition assessment by optical on-line dialysis adequacy monitor.

M Luman1, J Jerotskaja, K Lauri, I Fridolin.   

Abstract

AIM: In light of the variability of dialysis sessions, on-line monitoring could improve hemodialysis (HD) adequacy. A new optical Dialysis Adequacy Monitor (DIAMON) prototype enables to estimate dialysis dose and protein nitrogen appearance (PNA) at every dialysis session. The aim of this study was to compare the adequacy of dialysis treatment and the patient's nutritional status by pre-and post-dialysis blood samples, the DIAMON prototype and Total Dialysate Collection (TDC).
MATERIAL AND METHODS: Ten patients were monitored during three consecutive hemodialysis sessions during one week. Blood samples were drawn before the start of dialysis and at the end of dialysis. The DIAMON prototype was connected to the fluid outlet of the dialysis machine with all spent dialysate passing through during the on-line experiments, and TDC was performed for all dialysis treatments. Equilibrated Kt/V (eKt/V) values were estimated from blood-urea (eKt/Vb) and from DIAMON (eKt/Va), and normalized PNA (nPNA) values from TDC and DIAMON, respectively. The variable volume single pool urea kinetic modeling (VVSP UKM) was also utilized for single-pool Kt/V (spKt/V) and nPNA estimation.
RESULTS: The mean +/- SD given by eKt/Vb was 1.08 +/- 0.22 (n = 30), and eKt/Va 1.05 +/- 0.21 (n = 28). The mean +/- SD of nPNA was 0.73 +/- 0.15 g/kg/day (n = 29) from TDC, and 0.73 +/- 0.14 g/kg/day (n = 28) using DIAMON prototype. The mean values of eKt/V from blood samples and nPNA from TDC were not statistically different from the corresponding values estimated by DIAMON (p < 0.05). Generally the delivered dialysis dose and dietary protein intake of the patients observed during the study using the DIAMON prototype was very similar to that obtained by TDC and VVSP UKM.
CONCLUSION: The optical dialysis adequacy sensor, DIAMON, provides continuous, on-line measurements of dialysis adequacy and permits longitudinal analysis of the delivered dialysis dose and patient's nutritional status, and can immediately identify, and alert to, any deviations in dialysis treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825337     DOI: 10.5414/cnp72303

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Metabolic acidosis status and mortality in patients on the end stage of renal disease.

Authors:  Vaia D Raikou
Journal:  J Transl Int Med       Date:  2016-12-30

2.  The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1.

Authors:  Vaia D Raikou; Vasilios Kardalinos; Despina Kyriaki
Journal:  Kidney Dis (Basel)       Date:  2017-11-17

3.  Do only small uremic toxins, chromophores, contribute to the online dialysis dose monitoring by UV absorbance?

Authors:  Jürgen Arund; Risto Tanner; Fredrik Uhlin; Ivo Fridolin
Journal:  Toxins (Basel)       Date:  2012-10-18       Impact factor: 4.546

4.  Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzate.

Authors:  Li Zhang; Wenhu Liu; Chuanming Hao; Yani He; Ye Tao; Shiren Sun; Marten Jakob; Daniele Marcelli; Claudia Barth; Xiangmei Chen
Journal:  Int J Artif Organs       Date:  2021-11-23       Impact factor: 1.595

5.  Paracetamol interference in uric Acid levels in uremic patients revealed by monitoring spent dialysate.

Authors:  Risto Tanner; Jürgen Arund; Ivo Fridolin; Merike Luman
Journal:  ISRN Nephrol       Date:  2013-10-03

6.  Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease.

Authors:  Vaia Raikou; Vasilios Kardalinos; Despina Kyriaki
Journal:  J Cardiovasc Dev Dis       Date:  2018-06-21

7.  Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.

Authors:  Joosep Paats; Annika Adoberg; Jürgen Arund; Ivo Fridolin; Kai Lauri; Liisi Leis; Merike Luman; Risto Tanner
Journal:  Toxins (Basel)       Date:  2021-03-31       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.